CENTER LABORATORIES INC has a total of 29 patent applications. It decreased the IP activity by 61.0%. Its first patent ever was published in 2015. It filed its patents most often in United States, Republic of Korea and Taiwan. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are SOLUPRIN PHARMACEUTICALS INC, EPIZON PHARMA INC and DESITIN ARZNEIMITTEL GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | Republic of Korea | 3 | |
#3 | Taiwan | 3 | |
#4 | Australia | 2 | |
#5 | Canada | 2 | |
#6 | China | 2 | |
#7 | EPO (European Patent Office) | 2 | |
#8 | Brazil | 1 | |
#9 | Hong Kong | 1 | |
#10 | Israel | 1 | |
#11 | Japan | 1 | |
#12 | Mexico | 1 | |
#13 | Russian Federation | 1 | |
#14 | Singapore | 1 | |
#15 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Organic chemistry methods | |
#4 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Lee Meng-Ju | 21 |
#2 | Hsu Jui-Pao | 19 |
#3 | Shane Guang-Tzuu | 19 |
#4 | Yeh Yu-Yin | 19 |
#5 | Liao Yi-Ping | 13 |
#6 | Chang Shu-Hsien | 4 |
#7 | Meng-Ju Lee | 4 |
#8 | Jui-Pao Hsu | 3 |
#9 | Yu-Yin Yeh | 3 |
#10 | Yi-Ping Liao | 3 |
Publication | Filing date | Title |
---|---|---|
KR20190143386A | ORAL pH INDEPENDENT DOSAGE FORMULATION FOR TREATING NEURODEGENERATIVE DISORDERS | |
US2019321327A1 | Method of treating hyperglycemia | |
US2019321326A1 | Method of treating hyperglycemia | |
BR112018073688A2 | Hyperglycemia treatment method | |
EP3212611A1 | Crystal forms of verapamil hydrochloride |